Invention Grant
- Patent Title: Tumor-targeting compounds
-
Application No.: US15255847Application Date: 2016-09-02
-
Publication No.: US10202421B2Publication Date: 2019-02-12
- Inventor: Andre Koltermann
- Applicant: SKU Asset Management GmbH
- Agency: Ballard Spahr LLP
- Priority: EP09000406 20090114
- Main IPC: C07K7/08
- IPC: C07K7/08 ; C07K7/06 ; A61K47/64 ; A61K38/00
Abstract:
The invention relates to a novel compounds targeting human cancer cells, a method for synthesis of such compounds, and use of such compounds in treating cancer.
Public/Granted literature
- US20170096452A1 Novel Tumor-Targeting Compounds Public/Granted day:2017-04-06
Information query
